Diversity and prevalence of somatic mutations in the thyrotropin receptor and G(s)α genes as a cause of toxic thyroid adenomas

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 8, 1997, Pages 2695-2701

  Parma, Jasmine ^a   Duprez, Laurence ^a,f   Van Sande, Jacqueline ^a   Hermans, Jacques ^b   Rocmans, Pierre ^c   Van Vliet, Guy ^d   Costagliola, Sabine ^a   Rodien, Patrice ^a   Dumont, Jacques E ^a   Vassart, Gilbert ^a,e  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b Centre Hospitalier Jolimont Lobbes   (Belgium)

^c ERASME HOSPITAL   (Belgium)

^d UNIVERSITY OF MONTREAL   (Canada)

^e FREE UNIVERSITY OF BRUSSELS   (Belgium)

^f NONE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN RECEPTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; COHORT ANALYSIS; ENZYME ACTIVITY; GENE MUTATION; GENE SEQUENCE; HUMAN; LEUKOCYTE COUNT; PREVALENCE; PRIORITY JOURNAL; RECEPTOR BINDING; THYROID ADENOMA;

ADENOMA; ADULT; AGED; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BELGIUM; COS CELLS; CYCLIC AMP; DNA MUTATIONAL ANALYSIS; FEMALE; GENE DELETION; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; INOSITOL PHOSPHATES; MALE; MIDDLE AGED; MUTATION; RECEPTORS, THYROTROPIN; THYROID NEOPLASMS; THYROTROPIN; TRANSFECTION;

EID: 8544221172     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.8.2695     Document Type: Article

References (41)

1. Spiegel AM. 1996 Mutations in G proteins and G protein-coupled receptors in endocrine diseases. J Clin Endocrinol Metab. 81:2434-2442.
2. Dumont JE, Lamy F, Roger P, Maenhaut C. 1992 Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol Rev. 72:667-697.
3. Lefkowitz RJ, Cotecchia S, Samama P, Costa T. 1994 Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins, TiPS. 14:303-307.
4. Conklin BR, Bourne HR. 1993 Structural elements of G alpha subunits that interact with G beta gamma, receptors, and effectors. Cell. 73:631-641.
5. Parma J, Duprez L, Van Sande J, et al. 1993 Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature. 365:649-651.
6. Suarez HG, du Villard JA, Caillou B, Schlumberger M, Parmentier C, Monier R. 1991 gsp mutations in human thyroid tumours. Oncogene. 6:677-679.
7. O'Sullivan C, Barton CM, Staddon SL, Brown CL, Lemoine NR. 1991 Activating point mutations of the gsp oncogene in human thyroid adenomas. Mol Carcinog. 4:345-349.
8. Porcellini A, Ciullo I, Laviola L, Amabile A, Fenzi G, Avvedimento V. 1994 Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab. 79:657-661.
9. Takeshita A, Nagayama Y, Yokoyama N, et al. 1995 Rarity of oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in Japan. J Clin Endocrinol Metab. 80:2607-2611.
10. Russo D, Arturi F, Suarez HG, et al. 1996 Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab. 81:1548-1551.
11. Matsuo K, Friedman E, Gejman PV, Fagin JA. 1993 The thyrotropin receptor (TSH-R) is not an oncogene for thyroid tumors: structural studies of the TSH-R and the alpha-subunit of Gs in human thyroid neoplasms. J Clin Endocrinol Metab. 76:1446-1451.
12. Parma J, Van Sande J, Swillens S, Tonacchera M, Dumont JE, Vassart G. 1995 Somatic mutations causing constitutive activity of the TSH receptor are the major cause of hyperfunctional thyroid adenomas: identification of additional mutations activating both the cAMP and inositolphosphate-Ca++ cascades. Mol Endocrinol. 9:725-733.
13. Van Sande J, Parma J, Tonacchera M, Swillens S, Dumont J, Vassart G. 1995 Somatic and germline mutations of the TSH receptor gene in thyroid diseases. J Clin Endocrinol Metab. 80:2577-2585.
14. Masters SB, Landis CA, Bourne HR. 1990 GTPase-inhibiting mutations in the alpha subunit of Gs. Adv Second Messenger Phosphoprotein Res. 24:70-75.
15. Van Sande J, Lamy F, Lecocq R, et al. 1988 Pathogenesis of autonomous thyroid nodules: in vitro study of iodine and adenosine 3′,5′-monophosphate metabolism. J Clin Endocrinol Metab. 66:570-579.
16. Lyons J, Landis CA, Harsh G, et al. 1990 Two G protein oncogenes in human endocrine tumors. Science. 249:655-659.
17. Libert F, Lefort A, Gerard C, et al. 1989 Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: evidence for binding of autoantibodies. Biochem Biophys Res Commun. 165:1250-1255.
18. Tonacchera M, Van Sande J, Cetani F, et al. 1996 Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia. J Clin Endocrinol Metab. 81:547-554.
19. Johnstone AP, Cridland JC, DaCosta CR, Harfst E, Shepherd PS. 1994 Monoclonal antibodies that recognize the native human thyrotropin receptor. Mol Cell Endocrinol. 105:R1-R9.
20. Van Sande J, Massart C, Costagliola S, et al. 1996 Specific activation of the thyrotropin receptor by trypsin. Mol Cell Endocrinol. 119:161-168.
21. Paschke R, Tonacchera M, Van Sande J, Parma J, Vassart G. 1994 Identification and functional characterization of two new somatic mutations causing constitutive activation of the TSH receptor in hyperfunctioning autonomous adenomas of the thyroid. J Clin Endocrinol Metab. 79:1785-1789.
22. Russo D, Arturi F, Wicker R, et al. 1995 Genetic alterations in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab. 80:1347-1351.
23. Duprez L, Hermans J, Van Sande J, Dumont JE, Vassart G, Parma J. 1997 Two autonomous nodules of a patient with multinodular goiter harbor different activating mutations of the thyrotropin receptor gene. J Clin Endocrinol Metab. 82:306-308.
24. Kopp P, Van Sande J, Parma J, et al. 1995 Congenital non-autoimmune hyperthyroidism caused by a neomutation in the thyrotropin receptor gene. N Engl J Med. 332:150-154.
25. de Roux N, Polak M, Couet J, et al. 1996 A neomutation of the TSH receptor in a severe neonatal hyperthyroidism. J Clin Endocrinol Metab. 81:2023-2026.
26. Duprez L, Parma J, Dumont JE, Hermans J, Vassart G. 1996 Diversity and prevalence of somatic mutations in the TSH receptor gene as a cause of toxic adenoma. J Endocrinol Invest. 19:69.
27. Vassart G, Dumont JE, Refetoff S. 1995 Thyroid disorders. In: Beaudet AL, Seriver CR, Sly WS, Vale D, eds. The metabolic and molecular basis of inherited diseases. New York; McGraw-Hill; 2883-2928.
28. Vassart G, Parma J, Van Sande J, Dumont J. 1994 The thyrotropin receptor and the regulation of thyrocyte function and growth: update 1994. Endocr Rev. 3:77-80.
29. Ledent C, Dumont JE, Vassart G, Parmentier M. 1992 Thyroid expression of an A2 adenosine receptor transgene induces thyroid hyperplasia and hyperthyroidism. EMBO J. 11:537-542.
30. Michiels FM, Caillou B, Talbot M, et al. 1994 Oncogenic potential of guanine nucleotide stimulatory factor alpha subunit in thyroid glands of transgenic mice. Proc Natl Acad Sci USA. 91:10488-10492.
31. Wynford TD. 1993 Molecular basis of epithelial tumorigenesis: the thyroid model. Crit Rev Oncog. 4:1-23.
32. Roger P, Reuse S, Maenhaut C, Dumont JE. 1995 Multiple facets of the modulation of growth by cAMP. Vitam Horm. 51:59-191.
33. Kakinuma A, Chazenbalk G, Filetti S, McLachlan SM, Rapoport B. 1996 Both the 5′ and 3′ noncoding regions of the thyrotropin receptor messenger ribonucleic acid influence the level of receptor protein expression in transfected mamalian cells. Endocrinology. 137:2664-2669.
34. Duprez L, Parma J, Van Sande J, et al. 1994 Germline mutations in the thyrotropin receptor gene cause nonautoimmune autosomal dominant hyperthyroidism. Nat Genet. 7:396-401.
35. Kjelsberg MA, Cotecchia S, Ostrowski J, Caron MG, Lefkowitz RJ. 1992 Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. J Biol Chem. 267:1430-1433.
36. Cotecchia S, Exum S, Caron MG, Lefkowitz RJ. 1990 Regions of the alpha 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function. Proc Natl Acad Sci USA. 87:2896-2900.
37. Nagayama Y, Rapoport B. 1992 The thyrotropin receptor 25 years after its discovery: new insight after its molecular cloning. Mol Endocrinol. 6:145-156.
38. Kosugi S, Mori T. 1995 TSH receptor and LH receptor, 1995. Endocrine J 42:587-606.
39. Strader CD, Fong TM, Tota MR, Underwood D. 1994 Structure and function of G protein-coupled receptors. Annu Rev Biochem. 63:101-132.
40. Russo D, Arturi F, Schlumberger M, Caillou B, Filetti S, Suarez HG. 1995 Activating mutations of the TSH receptor in differentiated thyroid carcinomas. Oncogene. 11:1907-1911.
41. sα in human thyroid cancers: low prevalence of mutations predicts infrequent involvement in malignant transformation. J Clin Endocrinol Metab. 81:3898-3901.